Clinuvel Pharmaceuticals Limited (CUVL)
NASDAQ: CUVL · Real-Time Price · USD
4.940
-0.090 (-1.79%)
At close: Oct 23, 2026, 4:00 PM EDT
4.975
+0.035 (0.71%)
After-hours: Oct 23, 2026, 4:10 PM EDT
Clinuvel Pharmaceuticals Market Cap
Clinuvel Pharmaceuticals has a market cap or net worth of $252.53 million as of October 23, 2026.
Market Cap
252.53M
Enterprise Value
76.61M
1-Year Change
n/a
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since July 20, 2026, Clinuvel Pharmaceuticals's market cap has decreased from $371.50M to $252.53M, a decrease of -32.02%. That is a compound annual growth rate of -77.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 248.00M | -1.78% |
| Oct 22, 2026 | 252.50M | -1.75% |
| Oct 21, 2026 | 257.00M | -1.34% |
| Oct 20, 2026 | 260.50M | -0.99% |
| Oct 19, 2026 | 263.10M | - |
| Oct 16, 2026 | 263.10M | 3.58% |
| Oct 15, 2026 | 254.00M | -4.55% |
| Oct 14, 2026 | 266.10M | -2.56% |
| Oct 13, 2026 | 273.10M | -2.50% |
| Oct 12, 2026 | 280.10M | -0.18% |
| Oct 9, 2026 | 280.60M | -0.18% |
| Oct 8, 2026 | 281.10M | -3.47% |
| Oct 7, 2026 | 291.20M | 2.32% |
| Oct 6, 2026 | 284.60M | -1.25% |
| Oct 5, 2026 | 288.20M | -4.79% |
| Oct 2, 2026 | 302.70M | 6.55% |
| Oct 1, 2026 | 284.10M | -5.05% |
| Sep 30, 2026 | 299.20M | 1.53% |
| Sep 29, 2026 | 294.70M | 2.08% |
| Sep 28, 2026 | 288.70M | 2.16% |
| Sep 25, 2026 | 282.60M | -2.62% |
| Sep 24, 2026 | 290.20M | -0.17% |
| Sep 23, 2026 | 290.70M | -0.17% |
| Sep 22, 2026 | 291.20M | - |
| Sep 21, 2026 | 291.20M | -1.69% |
View and export this data all the way back to 2026. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Abeona Therapeutics | 255.61M |
| Bicycle Therapeutics | 254.77M |
| Rocket Pharmaceuticals | 253.58M |
| Fate Therapeutics | 250.42M |
| Lineage Cell Therapeutics | 249.11M |
| AC Immune | 248.57M |
| Immuneering | 246.17M |
| Vanda Pharmaceuticals | 245.48M |